The Future of Specialty Drugs A Policy Discussion on Treatments & Affordability

Watch the live feed here
 The development of specialty drugs has had a profound effect on treating patients suffering from chronic conditions, but these treatments come at a high cost to consumers and drug companies alike.

On October 1, join The Hill & the USC Schaeffer Center for a policy forum on how to make these promising new treatments more accessible and affordable for patients who need them most, while improving the quality of care they receive. From the House’s 21st Century Cures legislation to payment reform, what are policymakers and healthcare industry leaders doing to combat the slow drug approval process and rising prescription drug costs for consumers? Legislators, academics, and healthcare experts will discuss the impact specialty drugs have already had on treatments for cancer, multiple sclerosis, rheumatoid arthritis, and other chronic conditions, and what Congress and health insurance companies can do to make these treatments more widely available.

Date: October 1, 2015
Time: 8:00 AM-noon

Location:
The Newseum
555 Pennsylvania Avenue, NW (8th Floor Conference Center)
Washington, DC 20001

PROGRAM INCLUDES:



In Conversation
SENATOR BILL CASSIDY (R-LA)
With Bob Cusack, Editor in Chief, The Hill

The Value of Specialty Drugs
(presented by USC Schaeffer Center)
JOSH OFMAN, M.D., M.S.H.S., Senior Vice President, Global Value and Access, Amgen
STEVEN PEARSON, M.D., MSc, FRCP, Founder and President, Institute for Clinical and Economic Review [ICER]
KATHERINE WILEMON, Founder and President, The FH Foundation
 
Moderated by
DANA GOLDMAN,Ph.D., Leonard D. Schaeffer Chair and Director, Schaeffer Center, USC
 
In conversation
PAUL GINSBURG, Ph.D., Director of Public Policy, Schaeffer Center, Norman Topping Chair in Medicine and Public Policy and Professor at the Sol Price School of Public Policy, USC
With: Bob Cusack, Editor in Chief, The Hill

Payment Reform for a Changing Pharmaceutical Landscape
(presented by USC Schaeffer Center)
AMY BASSANO, Director, Patient Care Models Group, Center for Medicare and Medicaid Innovation [CMMI]
MICHAEL KOLODZIEJ, M.D., National Medical Director, Oncology Solutions, Office, Aetna
BLASE POLITE, M.D., M.P.P., Associate Professor of Medicine, University of Chicago; Past Chair, Government Relations Committee, American Society of Clinical Oncology [ASCO]
 
Moderated by
DARIUS LAKDAWALLA, Ph.D., Quintiles Chair in Pharmaceutical Development and Regulatory Innovation, Schaeffer Center, USC

 
Closing Remarks
DANA GOLDMAN,Ph.D., Leonard D. Schaeffer Chair and Director, Schaeffer Center, USC

REGISTER HERE TO ATTEND

Get updates on this event, or share your thoughts with @TheHillEvents & @SchaefferCenter using #SpecializedRx

 

Event Date
Location